Minireviews
Copyright ©The Author(s) 2021.
World J Diabetes. Oct 15, 2021; 12(10): 1719-1730
Published online Oct 15, 2021. doi: 10.4239/wjd.v12.i10.1719
Table 3 Glycemic targets in intensive care unit by casemix and variability
Casemix
Blood sample
Method
Glycemic target
Evidence
Medical-surgicalArterial, venousGlucometerGlucose variability (COV ≥ 20%)Increased ICU and hospital mortality in patients without DM; Obs[26]
Medical-surgicalArterial, capillaryGlucometer or blood gas analyzerGlucose variability > 6 mmol/LIncreased ICU and hospital mortality; Obs[44]
Medical-surgicalArterialGlucometer or blood gas analyzerGlucose variability > 4 mmol/LIncreased hospital mortality; Obs[10]
Post-CAArterialBlood gas analyzerGlucose variability < 5 mmol/LDecreased hypoglycemia and mortality; Obs[45]
Post-CANot statedNot statedGG-min < 3.9 mmol/LBetter neurological recovery; Obs[95]